Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Ischemic Heart Disease

  Free Subscription


20.10.2025

1 AJR Am J Roentgenol
2 Am Heart J
3 Am J Cardiol
1 Ann Intern Med
1 Arterioscler Thromb Vasc Biol
10 Atherosclerosis
1 Can J Cardiol
1 Catheter Cardiovasc Interv
2 Chest
1 Circ Arrhythm Electrophysiol
1 Circ Cardiovasc Imaging
2 Circ Cardiovasc Qual Outcomes
2 Circ Genom Precis Med
4 Circulation
2 Clin Cardiol
4 Eur Heart J
1 Heart
1 Hypertension
9 Int J Cardiol
1 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
1 J Clin Invest
1 J Electrocardiol
1 J Mol Cell Cardiol
2 JAMA
1 Mol Cell Biochem
3 PLoS One
1 Thromb Haemost


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. ZHOU Q
    Dynamic Microvascular Obstruction Assessment on Cardiac MRI: A Prognostic Barometer for Patients With ST-Elevation Myocardial Infarction.
    AJR Am J Roentgenol. 2025 Oct 15. doi: 10.2214/AJR.25.34027.
    PubMed        


    Am Heart J

  2. GOLD M, Kulkarni S, Quyyumi A
    Response to letter by Hu regarding article, "Statistical Methodological Limitations and Improvement Suggestions in the Study of Vitamin D Deficiency and Cardiovascular Mortality After Heart Transplantation.".
    Am Heart J. 2026;291:218-219.
    PubMed        

  3. HU H, Wang L
    Statistical methodological limitations and improvement suggestions in the study of vitamin D deficiency and cardiovascular mortality after heart transplantation.
    Am Heart J. 2026;291:216-217.
    PubMed        


    Am J Cardiol

  4. CORBALLIS N, Merinopoulos I, Bhalraam U, Natarajan R, et al
    Comparison of Drug Coated Balloon with Drug Eluting Stent for Isolated Ostial Side-Branch Coronary Artery Bifurcation Lesions.
    Am J Cardiol. 2025 Oct 14:S0002-9149(25)00621.
    PubMed        

  5. PARK BE, Choi KU, Choi JY, Kim H, et al
    Association Between High-Density Lipoprotein Cholesterol and the Risk of Cardiovascular Disorders: A Cohort Study of Healthy Adults.
    Am J Cardiol. 2025 Oct 9:S0002-9149(25)00630.
    PubMed         Abstract available

  6. ISHIMATSU T, Fukumoto Y
    Risk reduction by IMPELLA support in high-risk percutaneous coronary intervention.
    Am J Cardiol. 2025 Oct 9:S0002-9149(25)00624.
    PubMed        


    Ann Intern Med

  7. KITTLESON MM
    Chronic Coronary Artery Disease.
    Ann Intern Med. 2025 Oct 14. doi: 10.7326/ANNALS-25-03512.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  8. ABOHASHEM S, Saeed F, Munzel T, Al Kindi S, et al
    Imaging Findings Associated With Socioenvironmental Exposures Inform Mechanisms of Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2025 Oct 9. doi: 10.1161/ATVBAHA.125.322470.
    PubMed         Abstract available


    Atherosclerosis

  9. MANUBOLU VS, Kinninger A, Lakshmanan S, Dahal S, et al
    Ethnic differences in coronary plaque burden and characteristics: A matched CCTA cohort study of South Asians and non-Hispanic Whites.
    Atherosclerosis. 2025;409:120455.
    PubMed         Abstract available

  10. ATALLAH M, Harb T, Nasrallah N, Jones SR, et al
    Oxidized phospholipid dynamics in the early post-infarction period: Effects of PCSK9 inhibition with evolocumab.
    Atherosclerosis. 2025;409:120469.
    PubMed         Abstract available

  11. GIZARD F, Mohamedi N
    Influence of a mitochondria-associated membranes (MAMs) linker protein on coronary calcification: Commentary on "GRP75 inhibition attenuates arterial calcification" by Heyn J et al. Atherosclerosis 2025.
    Atherosclerosis. 2025;409:120497.
    PubMed         Abstract available

  12. XU Q, Jin C, Qin Z, Zhao P, et al
    Ambient temperature and coronary plaque rupture risk in STEMI: Insights from OCT analysis.
    Atherosclerosis. 2025;409:120510.
    PubMed         Abstract available

  13. TSCHARRE M, Mutschlechner D, Huber K, Gremmel T, et al
    Antiplatelet therapy with clopidogrel versus aspirin in atherosclerotic cardiovascular disease: a systematic review and meta-analysis.
    Atherosclerosis. 2025;409:120478.
    PubMed         Abstract available

  14. ARTHI SRI AS, Veeraraghavan VP, Patil S, Raj AT, et al
    Identification of salivary inflammatory non coding RNA biomarkers for coronary artery disease through epicardial adipose tissue gene network analysis.
    Atherosclerosis. 2025;409:120486.
    PubMed         Abstract available

  15. ARNOLD N, Gossling A, Weimann J, Bay B, et al
    Occurrence of coronary events in the absence of traditional risk factors: Understanding residual risk.
    Atherosclerosis. 2025;409:120475.
    PubMed         Abstract available

  16. SILBERNAGEL G, Higbie H, Meininger T, Lemen D, et al
    Associations of ANGPTL proteins and complexes with progression of coronary artery calcification and coronary events.
    Atherosclerosis. 2025;409:120485.
    PubMed         Abstract available

  17. KITAHARA S, Kataoka Y, Nicholls SJ, Funabashi S, et al
    Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trial.
    Atherosclerosis. 2025;409:120470.
    PubMed         Abstract available

  18. AHN WJ, Rha SW, Choi BG, Choi SY, et al
    Long-term clinical outcomes according to first responsive dose of acetylcholine in patients with coronary artery spasm.
    Atherosclerosis. 2025;409:120473.
    PubMed         Abstract available


    Can J Cardiol

  19. IZUMI A, Yau TM, Fedak PWM, Fatehi Hassanabad A, et al
    Pericardial Delivery of Stem Cells: An Emerging Frontier in Myocardial Regeneration for Ischemic Heart Disease.
    Can J Cardiol. 2025 Oct 14:S0828-282X(25)01214.
    PubMed         Abstract available


    Catheter Cardiovasc Interv

  20. GUILLON B, Besutti M, Revel L, Seronde MF, et al
    Absolute Coronary Flow Reduction Mediated by Microvascular Resistance in Myocardial Infarction: The FLOVITA Study.
    Catheter Cardiovasc Interv. 2025 Oct 13. doi: 10.1002/ccd.70268.
    PubMed         Abstract available


    Chest

  21. DE-TORRES JP, Casanova C, Zagaceta J, Marin JM, et al
    Cardiovascular Events in COPD: Complementary Role of Cardiac Risk and Coronary Artery Calcium Scores.
    Chest. 2025 Oct 14:S0012-3692(25)05526-6. doi: 10.1016/j.chest.2025.
    PubMed         Abstract available

  22. CISTULLI PA, Malik AS, Benjafield AV, Alpert N, et al
    Impact of Positive Airway Pressure Therapy on Healthcare Resource Use in Patients with Obstructive Sleep Apnea and Coronary Artery Disease.
    Chest. 2025 Oct 9:S0012-3692(25)05488-1. doi: 10.1016/j.chest.2025.
    PubMed         Abstract available


    Circ Arrhythm Electrophysiol

  23. XIE A, Kang GJ, Liu H, Kim EJ, et al
    Lysosomal Ca(2+) Release Through TRPML1 Governs Ventricular Arrhythmia After Myocardial Infarction.
    Circ Arrhythm Electrophysiol. 2025 Oct 14:e013964.
    PubMed         Abstract available


    Circ Cardiovasc Imaging

  24. LOPEZ DM, Huck D, Divakaran S, Brown JM, et al
    Utility of (18)F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery Disease.
    Circ Cardiovasc Imaging. 2025 Oct 9:e018323. doi: 10.1161/CIRCIMAGING.125.018323
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  25. WALLINS JS, Kini V
    What Is the Value of Routine Cardiovascular Care? Potential Lessons From the COVID-19 Pandemic.
    Circ Cardiovasc Qual Outcomes. 2025 Oct 9:e012788.
    PubMed        

  26. OSERAN AS, Aggarwal R, Wadhera RK
    Cardiovascular Risk Factor Management in Medicare Advantage and Traditional Medicare.
    Circ Cardiovasc Qual Outcomes. 2025 Oct 9:e012143.
    PubMed         Abstract available


    Circ Genom Precis Med

  27. MCGURK KA, Curran L, Sau A, Ng FS, et al
    Circulating Cardiovascular Proteomic Associations With Genetics and Disease.
    Circ Genom Precis Med. 2025 Oct 7:e005005. doi: 10.1161/CIRCGEN.124.005005.
    PubMed         Abstract available

  28. CHHAY P, Tang O, Ai L, Cordwell SJ, et al
    Digging Deeper Into Cardiovascular Plasma Proteomics: Opportunities and Limitations of Current Platforms.
    Circ Genom Precis Med. 2025 Oct 6:e005198. doi: 10.1161/CIRCGEN.125.005198.
    PubMed         Abstract available


    Circulation

  29. FORAKER R, Sperling L, Bratzke L, Budoff M, et al
    Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Oct 16. doi: 10.1161/CIR.0000000000001382.
    PubMed         Abstract available

  30. KHAN SS, Fisher SA
    Bending the Curve in Maternal Mortality: Pregnancy as a Moment for Cardiovascular Disease Prevention.
    Circulation. 2025;152:1056-1059.
    PubMed        

  31. OREN O, Libby P
    Incorporating Management of Clonal Hematopoiesis of Indeterminate Potential Into Cardiovascular Practice.
    Circulation. 2025;152:975-977.
    PubMed        

  32. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
    Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
    Circulation. 2025;152:1044-1055.
    PubMed         Abstract available


    Clin Cardiol

  33. KONIG S, Hohenstein S, Leiner J, Nitsche A, et al
    Management of Antithrombotic Therapy in Patients With Coexisting Atrial Fibrillation and Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention Within the Last Year.
    Clin Cardiol. 2025;48:e70196.
    PubMed         Abstract available

  34. YU H, Li S, Wu Y, Ren X, et al
    Prognostic Value of Platelet to Lymphocyte Ratio for Myocardial Infarction: A Systematic Review and Meta-Analysis.
    Clin Cardiol. 2025;48:e70215.
    PubMed         Abstract available


    Eur Heart J

  35. CREA F
    Ischaemic heart disease: changing landscape of risk stratification, importance of coronary stenosis functional assessment, optimal timing of anticoagulation in ST elevation myocardial infarction.
    Eur Heart J. 2025;46:3799-3804.
    PubMed        

  36. ARAI R, Kojima K, Fukamachi D, Okumura Y, et al
    DanGer shock criteria and outcomes in acute myocardial infarction-related cardiogenic shock treated with Impella: the J-PVAD registry.
    Eur Heart J. 2025 Oct 13:ehaf787. doi: 10.1093.
    PubMed         Abstract available

  37. MANGIACAPRA F, Paolucci L, De Bruyne B, Rioufol G, et al
    Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis.
    Eur Heart J. 2025 Aug 20:ehaf504. doi: 10.1093.
    PubMed         Abstract available

  38. CHEN J, Xu C, Qiu L, Li B, et al
    Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial.
    Eur Heart J. 2025 Aug 1:ehaf481. doi: 10.1093.
    PubMed         Abstract available


    Heart

  39. YE Y, Feng W, Ding Y, Chen Q, et al
    Retinal image-based deep learning for mild cognitive impairment detection in coronary artery disease population.
    Heart. 2025;111:1013-1019.
    PubMed         Abstract available


    Hypertension

  40. LIN YJ, Li JP, Lai YC, Liu TY, et al
    Blood Pressure Genetics in Han Taiwanese With Cross-Trait Analysis in East Asians: Insights Into Comorbidities, All-Cause Mortality, and Cardiovascular Mortality.
    Hypertension. 2025 Oct 8. doi: 10.1161/HYPERTENSIONAHA.125.25321.
    PubMed         Abstract available


    Int J Cardiol

  41. LU H, Zhang Y, Yang P, Zhao H, et al
    Novel high-burden thrombus criterion: Thrombectomy plus thrombolysis improves microvascular resistance in myocardial infarction.
    Int J Cardiol. 2025;443:133970.
    PubMed         Abstract available

  42. KHALED S, Tantawi W, Ahmed WE, Shaikh M, et al
    The impact of post discharge virtual cardiac remote monitoring for patients with acute coronary syndrome during HAJJ season 1445H- KAMC experience.
    Int J Cardiol. 2026;442:133900.
    PubMed         Abstract available

  43. SAMY M, Allali A, Alotaibi S, Toelg R, et al
    Serial quantitative flow ratio measurements of a successfully recanalized coronary chronic total occlusion.
    Int J Cardiol. 2026;442:133897.
    PubMed         Abstract available

  44. YANG X, Li B, Chen H, Ding R, et al
    CCTA-quantified pericornary inflammation and lipoprotein (a): Combined predictive value in non-obstructive CAD.
    Int J Cardiol. 2026;442:133887.
    PubMed         Abstract available

  45. MANEGAONKAR SM, Effat MA, van de Hoef TP, Lee JM, et al
    Delineating coronary epicardial stenosis status from microvascular dysfunction using pressure-drop coefficient from multicenter ILIAS registry.
    Int J Cardiol. 2025;442:133864.
    PubMed         Abstract available

  46. MORENO R, Baptista SB, Rivero-Santana B, Valencia J, et al
    Benefit of coronary stenting using available intracoronary tools in high-risk patients. The OPTI-XIENCE study.
    Int J Cardiol. 2026;442:133847.
    PubMed         Abstract available

  47. AL QARAGHULI A, Chitturi KR, Kumar S, Cellamare M, et al
    Exploring the impact of age on microvascular function: Insights from the Coronary Microvascular Disease Registry.
    Int J Cardiol. 2026;442:133858.
    PubMed         Abstract available

  48. RUMIZ E, Rivero F, Perez A, Nau G, et al
    ESP-INOCA: Rationale and design of a national multicentre registry for prognostic stratification in patients with suspected myocardial ischaemia and non-obstructive coronary arteries.
    Int J Cardiol. 2026;442:133845.
    PubMed         Abstract available

  49. SHOJAZADEH A, Hadjiabdolhamid N, Lee C, Antunes IM, et al
    Early detection of coronary artery disease using low-dose CT perfusion: An experimental western fat diet study.
    Int J Cardiol. 2026;442:133793.
    PubMed         Abstract available


    J Am Coll Cardiol

  50. HUANG X, Zhang H, Li Y, Ge J, et al
    Modest Effects of Intensive Blood Pressure-Lowering on Quality of Life in Patients at High Cardiovascular Risk: The ESPRIT trial.
    J Am Coll Cardiol. 2025 Jul 25:S0735-1097(25)06777.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  51. LI J, Li X, Chen Y, Fang L, et al
    Cardioprotective effects of soluble guanylate cyclase and its alpha1 subunit on myocardial ischemia/reperfusion injury via the PGC-1alpha/UCP2 pathway.
    J Cardiovasc Pharmacol. 2025 Oct 13. doi: 10.1097/FJC.0000000000001765.
    PubMed         Abstract available


    J Clin Invest

  52. WANG X, Yan X, Mang G, Chen Y, et al
    S100a9 lactylation triggers neutrophil trafficking and cardiac inflammation in myocardial ischemia/reperfusion injury.
    J Clin Invest. 2025 Oct 9:e194664. doi: 10.1172/JCI194664.
    PubMed         Abstract available


    J Electrocardiol

  53. EFE SC, Karacam M, Tekatli AF, Bozan B, et al
    The value of P wave parameters in predicting proximal or distal right coronary artery occlusion in patients with inferior myocardial infarction.
    J Electrocardiol. 2025;93:154143.
    PubMed         Abstract available


    J Mol Cell Cardiol

  54. WANG Y, Li Y, Zhou Y, Zhang H, et al
    Nynrin enhances cardiac function by inhibiting mitochondrial permeability transition pore opening upon myocardial ischemia/reperfusion injury.
    J Mol Cell Cardiol. 2025 Oct 10:S0022-2828(25)00180.
    PubMed         Abstract available


    JAMA

  55. HERRMANN FEM, Jeppsson A, Kirov H, Charitos EI, et al
    Long-Term Continuous Monitoring of New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting.
    JAMA. 2025 Oct 9:e2514891. doi: 10.1001/jama.2025.14891.
    PubMed         Abstract available

  56. PANT S
    Cardiovascular Conditions Lead Global Disease Burden Over the Past 30 Years.
    JAMA. 2025 Oct 17. doi: 10.1001/jama.2025.17515.
    PubMed        


    Mol Cell Biochem

  57. LI J, Li Y, Shen Q, Zhang Y, et al
    The Yin and Yang of copper in cardiovascular health and disease.
    Mol Cell Biochem. 2025 Oct 10. doi: 10.1007/s11010-025-05401.
    PubMed         Abstract available


    PLoS One

  58. PETROS A, Melkie A, Kotiso KS, Kebede D, et al
    Peripheral line for vasopressor administration: Prospective multicenter observational cohort study for survival and safety.
    PLoS One. 2025;20:e0333275.
    PubMed         Abstract available

  59. KIM H, Lee SW, Lim Y, Han N, et al
    Comparison of ischemic cardiovascular events between dapagliflozin and empagliflozin in combination with metformin: A nationwide population-based cohort study.
    PLoS One. 2025;20:e0333604.
    PubMed         Abstract available

  60. HE C, Peng J, Liu H, Zhong L, et al
    A study protocol of the rehabilitative efficacy of cardiovascular ultrasound therapy after percutaneous coronary intervention in patients with coronary artery disease: A multicenter, parallel-group, randomized controlled study.
    PLoS One. 2025;20:e0327557.
    PubMed         Abstract available


    Thromb Haemost

  61. ORTEGA-PAZ L, Ueki Y, Laudani C, Losdat S, et al
    Impact of PCSK9 inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled analysis of two Randomized Trials.
    Thromb Haemost. 2025 Oct 10. doi: 10.1055/a-2717-5994.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.